European Healthtech startup funding raised during August 2024.
In August 2024, 25 European Healthtech companies raised a combined €364M across 25 funding rounds, down 88.1% versus August 2023. Germany led by capital raised, and Aescuvest was the most active investor. Data as of 9 Jul 2026.
5 exits.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Caresyntax | Series C | Aug 2024 | €164M |
| Oxford Nanopore Technologies | Other | Aug 2024 | €59M |
| Healx | Other | Aug 2024 | €44M |
| Vandria | Series A |
| Aug 2024 |
| €28M |
| Hexarad | Other | Aug 2024 | €13M |
| PL BioScience | Other | Aug 2024 | €7.8M |
| XO Life | Other | Aug 2024 | €7.0M |
| Sanos | Other | Aug 2024 | €7.0M |
| Roger | Other | Aug 2024 | €7.0M |
| Biomatter | Seed | Aug 2024 | €6.5M |
| Thryve | Series A | Aug 2024 | €4.0M |
| Clare&me | Other | Aug 2024 | €3.7M |
| Release Therapeutics | Seed | Aug 2024 | €3.5M |
| NADMED | Other | Aug 2024 | €3.5M |
| Cellestetix | Other | Aug 2024 | €1.8M |
